TY - JOUR
T1 - Assessing the association of depression and anxiety with symptom reporting among individuals with type 2 diabetes
AU - Asman, Arielle G.
AU - Hoogendoorn, Claire J.
AU - McKee, M. Diane
AU - Gonzalez, Jeffrey S.
N1 - Publisher Copyright:
© 2019, Springer Science+Business Media, LLC, part of Springer Nature.
PY - 2020/2/1
Y1 - 2020/2/1
N2 - Depression and anxiety have been linked to increased somatic symptoms among individuals with type 2 diabetes (T2D), but their independent effects and role in symptom attributions remain unclear. This study examined depression and anxiety in relation to total symptoms and symptom attributions in a diverse sample of 120 adults with T2D. Multiple linear regression tested associations after controlling for medical comorbidities and insulin use. Clinician-rated depression (β =.53, p <.001), self-reported depression (β =.59, p <.001) and self-reported anxiety (β =.62, p <.001) were positively associated with total somatic symptoms. Models adjusting for depression and anxiety revealed significant independent effects for each, regardless of measurement method. In attribution models, only self-reported depression (β =.27, p =.003) was significantly associated with greater attribution to diabetes, whereas clinician-rated depression (β =.19, p =.047), self-reported depression (β =.38, p <.001) and anxiety (β =.28, p =.004) were associated with increased attribution to medications. In models adjusting for depression and anxiety, self-reported depression was a significant independent predictor of diabetes (β =.29, p =.023) and medication (β =.38, p =.004) attribution; anxiety was a significant predictor of medication attribution (β =.25, p =.039). Findings suggest depression and anxiety are implicated in overall increases in somatic symptom complaints and an increased tendency to attribute these symptoms to diabetes and side-effects of diabetes medications among adults with T2D.
AB - Depression and anxiety have been linked to increased somatic symptoms among individuals with type 2 diabetes (T2D), but their independent effects and role in symptom attributions remain unclear. This study examined depression and anxiety in relation to total symptoms and symptom attributions in a diverse sample of 120 adults with T2D. Multiple linear regression tested associations after controlling for medical comorbidities and insulin use. Clinician-rated depression (β =.53, p <.001), self-reported depression (β =.59, p <.001) and self-reported anxiety (β =.62, p <.001) were positively associated with total somatic symptoms. Models adjusting for depression and anxiety revealed significant independent effects for each, regardless of measurement method. In attribution models, only self-reported depression (β =.27, p =.003) was significantly associated with greater attribution to diabetes, whereas clinician-rated depression (β =.19, p =.047), self-reported depression (β =.38, p <.001) and anxiety (β =.28, p =.004) were associated with increased attribution to medications. In models adjusting for depression and anxiety, self-reported depression was a significant independent predictor of diabetes (β =.29, p =.023) and medication (β =.38, p =.004) attribution; anxiety was a significant predictor of medication attribution (β =.25, p =.039). Findings suggest depression and anxiety are implicated in overall increases in somatic symptom complaints and an increased tendency to attribute these symptoms to diabetes and side-effects of diabetes medications among adults with T2D.
KW - Anxiety
KW - Depression
KW - Diabetes mellitus
KW - Signs and symptoms
KW - Type 2
UR - http://www.scopus.com/inward/record.url?scp=85066138852&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85066138852&partnerID=8YFLogxK
U2 - 10.1007/s10865-019-00056-x
DO - 10.1007/s10865-019-00056-x
M3 - Article
AN - SCOPUS:85066138852
SN - 0160-7715
VL - 43
SP - 57
EP - 68
JO - Journal of Behavioral Medicine
JF - Journal of Behavioral Medicine
IS - 1
ER -